Parallax Volatility Advisers
CMD

Parallax Volatility Advisers’s Cantel Medical Corporation CMD Stock Holding History

Parallax Volatility Advisers’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-4,082
Closed -$329K – 3805
2019
Q2 		$329K Buy
+4,082
New +$287K ﹤0.01% 1618
2018
Q1 		– Sell
-5,544
Closed -$570K – 4861
2017
Q4 		$570K Buy
+5,544
New +$552K ﹤0.01% 1458

Other funds holding CMD

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Parallax Volatility Advisers's CMD Position: Q3 2019 in Review

Parallax Volatility Advisers sold out of Cantel Medical Corporation (CMD) in Q3 2019, closing a stake of 4,082 shares — an estimated $329K sold.

Parallax Volatility Advisers first reported a position in CMD in Q4 2017 and held it in 2 quarters. The position peaked at $570K in Q4 2017. 244 funds tracked by Wall St. Rank hold CMD as of Q3 2019.

  • Parallax Volatility Advisers reported no remaining Cantel Medical Corporation position as of Q3 2019 after selling out during the quarter.
  • Parallax Volatility Advisers sold 4,082 Cantel Medical Corporation shares in Q3 2019, an estimated $329K.
  • Parallax Volatility Advisers first reported a position in Cantel Medical Corporation in Q4 2017 and held it in 2 quarters.
  • Parallax Volatility Advisers's Cantel Medical Corporation position peaked at $570K in Q4 2017.
  • 244 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2019.

Based on Parallax Volatility Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.